Progress and potential in regenerative medicine.
A significant amount of regenerative medicine research is underway to better understand mesenchymal stem cells and how they could play a role in future cord tissue therapies – helping treat conditions once thought untreatable such as Parkinson’s disease, Type 1 diabetes and Autism.
New Areas of Potential Use: Cord Tissue and Autism
Phase I Clinical Trial – underway to determine the safety of one, two, and three intravenous infusions of human umbilical cord tissue-derived mesenchymal stromal cells (hCT-MSC), administered every two months, in children with Autism Spectrum Disorder (Autism).
Researchers are also focusing on a wide range of potential treatment areas, including Parkinson’s disease, Alzheimer’s, liver fibrosis, lung cancer, and sports injuries. Learn more about Emerging Research»